CLChen Li

Chen Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Chen Li has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Amorphous A‐BiOI@PEG Nanoenzyme Targets Imaging and Synergistic Phototherapy in Differentiated Thyroid Cancer

    by Chen Li, Mengmeng Zhang, Xiuyi Yang, Yingjiang Ye, Kewei Jiang, Lin Guo

    The integration of medical nanomaterials into cancer diagnosis and treatment presents a multifaceted challenge, given the simultaneous necessity of achieving high targeting and excellent diagnostic and therapeutic efficacy. Herein, a PEGylated amorphous BiOI (a‐BiOI@PEG) nanoenzyme is developed, whose abundant unsaturated bonds, iodine‐containing delivery systems, and reduced bandgap facilitate active/passive uptake by thyroid cancer cells and response to second near‐infrared (NIR‐II), respectively. This allows for accurate DTC‐specific targeting of tumor cells for ultrasound and computer tomography (CT) imaging and enhances synergistic phototherapy. Consequently, the results show that a‐BiOI@PEG outperforms the common CT contrast agent iohexol and B‐mode ultrasonography. This process is followed by the generation of remarkable ROS and an increase in temperatures above 48 ℃ in 10 min under 1064 nm NIR, inducing impressive immunogenic cell death and exerting long‐term anti‐tumor effects at primary and metastatic sites to prevent cancer metastasis, while normal cells are rarely killed. This study reveals the intricate relationship between amorphous structures and diagnostic integration, laying the foundation for the design of highly targeted and efficient amorphous nanoenzymes that simultaneously target thyroid tumors.


  • Open Access

    Risk of suicide in patients with thyroid cancer: protocol for a systematic review and meta-analysis

    by Chen Li, Mengmeng Zhang, Quan Wang, Kewei Jiang, Yingjiang Ye

    Introduction In recent years, the incidence of thyroid cancer has increased manyfold and young adults, who have a greater financial burden and occupational stress, comprise a large number. Previous studies have shown mixed results, even distinct results, on suicide rates among thyroid cancer survivors. As the overdiagnosis and overtreatment of thyroid cancer has gradually become a topical issue, the study aims to summarise the risk of suicide among patients with thyroid cancer to provide robust evidence of the effects of thyroid cancer on suicide. Methods and analysis A total of six databases (MEDLINE, Embase, Web of Science Core Collection, PsycINFO, CINAHL and Google Scholar) will be searched according to MeSH, subheadings, and free words, and the planned search date is 31 Jnauary 2024. The search strategy had three parts, such as suicide, cancer and epidemiological studies, moreover, we will collect the detailed suicide information by reviewers’ extraction. Standard mortality ratio (SMR) was used as the outcome measure, when SMRs were not available, the risk ratio, HR and detailed number of suicides were extracted to calculate the SMRs. Ethics and dissemination The Institutional Review Board of Peking University People’s Hospital provided ethical approval exemption and approved the data collection and subsequent analyses in accordance with the Declaration of Helsinki as revised in 2013. PROSPERO registration number CRD42023445542.

  • Open Access

    Characterization of Global Research Trends and Prospects on Single-Cell Sequencing Technology: Bibliometric Analysis

    by Quan Wang, Ke-Lu Yang, Zhen Zhang, Zhu Wang, Chen Li, Lun Li, Jin-Hui Tian, Ying-Jiang Ye, Shan Wang, Ke-Wei Jiang

    Background: As single-cell sequencing technology has been gradually introduced, it is essential to characterize global collaboration networks and map development trends over the past 20 years. Objective: The aim of this paper was to illustrate collaboration in the field of single-cell sequencing methods and explore key topics and future directions. Methods: Bibliometric analyses were conducted with CiteSpace and VOSviewer software on publications prior to November 2019 from the Web of Science Core Collection about single-cell sequencing methods. Results: Ultimately, we identified 2489 records, which were published in 495 journals by 14,202 authors from 1970 institutes in 61 countries. There was a noticeable increase in publications in 2014. The United States and high-income countries in Europe contributed to most of the records included. Harvard University, Stanford University, Karolinska Institutes, Peking University, and the University of Washington were the biggest nodes in every cluster of the collaboration network, and SA Teichmann, JC Marioni, A Regev, and FC Tang were the top-producing authors. Keywords co-occurrence analysis suggested applications in immunology as a developing research trend. Conclusions: We concluded that the global collaboration network was unformed and that high-income countries contributed more to the rapidly growth of publications of single-cell sequencing technology. Furthermore, the application in immunology might be the next research hotspot and developmental direction.


  • Open Access

    Different Medical Features and Strategies of Large Rectal Gastrointestinal Stromal Tumor: A Multi-Central Pooling Analysis

    by Chen Li, Hao Wu, Han Li, Quan Wang, Yang Li, Zhi-Dong Gao, Xiao-Dong Yang, Ying-Jiang Ye, Ke-Wei Jiang

    Purpose: The rectum is a rare site for gastrointestinal stromal tumors (GISTs). Tumors in this critical anatomical site are prone to develop local recurrence, and this occurs at a high level even in low-risk tumors. Previous studies found that high-risk was the most common category in rectal gastrointestinal stromal tumors (RGISTs), and size was the most important factor affecting the long-term prognosis. We aimed to find out the most influential factor on clinical outcomes, and describe demographics, oncological differences, and surgical procedures in patients with poor prognosis. Patients and Methods: Data on consecutive patients with RGIST, who were diagnosed at Peking University People’s Hospital, Shandong Province Hospital, and The First Affiliated Hospital of Shandong First Medical University from 2010 to 2020, were retrospectively evaluated. Further, a literature search was conducted by retrieving data from PubMed, EMBASE, and the Cochrane Library databases from inception up to March 20, 2020. Results: In all, 50 patients were diagnosed with RGIST at three medical centers, and 86 published records were finally included in the literature review. Combined analysis of the whole individual patient data showed that 5.5 cm was deemed an appropriate cut-off value for L-RGIST, and that patients usually showed a male predominance (67.59%), younger age at onset (56.61 years), higher operative difficulty, and poorer prognosis. Conclusion: Separation of patients with large RGIST from general patients may contribute to the recognition of the oncological characteristics and clinical management of this rare type of tumor.


  • Open Access

    Characterization of Global Research Trends and Prospects on Single-Cell Sequencing Technology: Bibliometric Analysis (Preprint)

    by Quan Wang, Ke-Lu Yang, Zhen Zhang, Zhu Wang, Chen Li, Lun Li, Jin-Hui Tian, Ying-Jiang Ye, Shan Wang, Ke-Wei Jiang

    BACKGROUND As single-cell sequencing technology has been gradually introduced, it is essential to characterize global collaboration networks and map development trends over the past 20 years. OBJECTIVE The aim of this paper was to illustrate collaboration in the field of single-cell sequencing methods and explore key topics and future directions. METHODS Bibliometric analyses were conducted with CiteSpace and VOSviewer software on publications prior to November 2019 from the Web of Science Core Collection about single-cell sequencing methods. RESULTS Ultimately, we identified 2489 records, which were published in 495 journals by 14,202 authors from 1970 institutes in 61 countries. There was a noticeable increase in publications in 2014. The United States and high-income countries in Europe contributed to most of the records included. Harvard University, Stanford University, Karolinska Institutes, Peking University, and the University of Washington were the biggest nodes in every cluster of the collaboration network, and SA Teichmann, JC Marioni, A Regev, and FC Tang were the top-producing authors. Keywords co-occurrence analysis suggested applications in immunology as a developing research trend. CONCLUSIONS We concluded that the global collaboration network was unformed and that high-income countries contributed more to the rapidly growth of publications of single-cell sequencing technology. Furthermore, the application in immunology might be the next research hotspot and developmental direction.